Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Encompass Health (EHC)

Encompass Health stockholders elect 10 directors, approve 2025 incentive plan

Neutral Impact 2 of 5 shareholder Written later

At its May 1, 2025 annual meeting, Encompass Health stockholders passed all four proposals: electing 10 directors, ratifying PricewaterhouseCoopers LLP as auditor, approving named executive officer compensation, and approving the 2025 Omnibus Performance Incentive Plan. The filing reports vote results and attaches the incentive plan as Exhibit 10.1, which shareholders can review for its terms.

Key points

  • All 10 director nominees were elected; Greg D. Carmichael received 87,805,760 votes for and 2,107,016 against.
  • PwC ratification passed with 91,374,755 votes for and 3,403,771 against.
  • Named executive officer compensation approval passed with 87,426,450 votes for and 2,187,504 against.
  • 2025 Omnibus Performance Incentive Plan passed with 85,524,738 votes for and 4,376,186 against, plus 4,876,924 broker non-votes.

The filing

CompanyEncompass Health (EHC)
Form8-K, current report
Filed with the SECMay 2, 2025, 2:33 PM ET
Accession number0000785161-25-000025

Items reported: 5.02 Director / Officer Change5.07 Shareholder Vote Results

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:12 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 02, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.